These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15359821)

  • 1. [Treatment of acute hepatitis C].
    Yokosuka O; Mikata R
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):357-60. PubMed ID: 15359821
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of acute hepatitis C].
    Grangé JD
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B32-7. PubMed ID: 12180306
    [No Abstract]   [Full Text] [Related]  

  • 3. [What are the indications for treatment of acute hepatitis C?].
    Myers RP; Regimbeau C; Moussalli J; Ratziu V; Di Martino V; Thabut D; Bernard B; Benhamou Y; Poynard T
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B188-93. PubMed ID: 12180287
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C: limits and dose regimen of interferon alfa.
    Prescrire Int; 1998 Oct; 7(37):150-4. PubMed ID: 10915423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three times weekly versus daily dose alpha-interferon treatment in patients with acute hepatitis C.
    Fabris P; Tositti G; Giordani MT; Infantolino D; de LF
    Am J Gastroenterol; 2002 Feb; 97(2):492-3. PubMed ID: 11866300
    [No Abstract]   [Full Text] [Related]  

  • 6. Maxim and Roche collaborate for development of hepatitis C drug.
    AIDS Read; 2000 Sep; 10(9):545. PubMed ID: 11019452
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of IFN treatment for extrahepatic manifestations].
    Matsumori A
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):569-73. PubMed ID: 15359863
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatitis C: therapeutic perspectives].
    Trépo C
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B297-302. PubMed ID: 12180304
    [No Abstract]   [Full Text] [Related]  

  • 9. Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial.
    Nomura H; Sou S; Tanimoto H; Nagahama T; Kimura Y; Hayashi J; Ishibashi H; Kashiwagi S
    Hepatology; 2004 May; 39(5):1213-9. PubMed ID: 15122749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How should hepatitis C be treated? Treatment of hepatitis C with interferon].
    Marcellin P
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S81-8. PubMed ID: 9161518
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon + ribavirin combination therapy. Open new approach to treatment of patients with hepatitis C virus.
    Iino S
    Ital J Gastroenterol Hepatol; 1999 Apr; 31(3):216-7. PubMed ID: 10379483
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferons in the management of viral hepatitis.
    Zein NN
    Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of interferon combined glycyrrhizin therapy in patients with interferon-resistant chronic hepatitis C].
    Okuno T; Arai K; Shindo M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1022-5. PubMed ID: 7563661
    [No Abstract]   [Full Text] [Related]  

  • 14. Retreatment of hepatitis C patients who do not respond to interferon: the search continues.
    Pianko S; McHutchison J
    Am J Gastroenterol; 2000 May; 95(5):1122-4. PubMed ID: 10811315
    [No Abstract]   [Full Text] [Related]  

  • 15. Ribavirin and interferon for recurrent posttransplantation HCV infection: to treat or not to treat?
    McHutchison JG
    Hepatology; 1997 Aug; 26(2):505-6. PubMed ID: 9252167
    [No Abstract]   [Full Text] [Related]  

  • 16. [Side effects of interferon-alpha].
    Vial T; Bailly F; Descotes J; Trepo C
    Gastroenterol Clin Biol; 1996; 20(5):462-89. PubMed ID: 8761145
    [No Abstract]   [Full Text] [Related]  

  • 17. A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
    Uyama H; Enomoto H; Kishima Y; Yamamoto M; Yoshida K; Okuda Y; Hirotani T; Kuroda T; Ito H; Matsuda M; Terabayashi M; Noguchi S; Kawase I; Nakamura H
    Hepatogastroenterology; 2003; 50(54):2112-6. PubMed ID: 14696476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
    Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual hepatitis B virus and hepatitis C virus infection: To treat or not to treat, and how?
    Husa P
    J Gastroenterol Hepatol; 2005 May; 20(5):669-70. PubMed ID: 15853976
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural beta interferon in acute type-C hepatitis patients: a randomized controlled trial.
    Calleri G; Colombatto P; Gozzelino M; Chieppa F; Romano P; Delmastro B; Macor A; Cariti G; Brunetto MR; Grillone W; Bonino F
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):181-4. PubMed ID: 9675655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.